SK

Sharatchandra Krishna Belvalkar

Active Director Director DIN 05132442
DIN 05132442 First appointment Apr 2003 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharatchandra Krishna Belvalkar

Data last updated:

Sharatchandra Krishna Belvalkar is a Director at Dhananjay Pharma Private Limited (since 2003). The company operates in Chemicals.

DIN 05132442
Primary Designation Director
Industry Chemicals
First Appointment 15 Apr 2003
Oldest Company Age 29 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dhananjay Pharma Private Limited U24231PN1996PTC014958
Director15 Apr 20031996Active

Board colleagues of Sharatchandra Krishna Belvalkar

Directorship timeline

Open interactive timeline →
Dhananjay Pharma Private Limited
Premium access

Shareholding and investment profile for Sharatchandra Krishna Belvalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharatchandra Krishna Belvalkar

Sharatchandra Krishna Belvalkar currently holds 1 directorship: Dhananjay Pharma Private Limited (Director, since 15 Apr 2003).

Sharatchandra Krishna Belvalkar was first appointed on 15 Apr 2003 as Director at Dhananjay Pharma Private Limited.

The current boards of Sharatchandra Krishna Belvalkar's companies include Mahesh Sharatchandra Belvalkar (Dhananjay Pharma Private Limited), Mohini Mahesh Belvalkar (Dhananjay Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available